Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chandraprabha Vati is a classical polyherbal Ayurvedic formulation traditionally used for the management of urinary tract disorders, metabolic syndrome, and reproductive health issues. It is composed of over 30 ingredients, including herbal components like Guggulu (Commiphora wightii) and Shilajit (Asphaltum punjabianum), as well as mineral supplements like iron and zinc. The formulation is recognized for its multi-target therapeutic profile, exhibiting anti-inflammatory, antioxidant, anti-hyperglycemic, and lipid-lowering activities. Clinical and preclinical studies indicate its efficacy in treating urinary tract infections (UTI) by modulating inflammatory markers such as TNF-α and NF-κB and restoring antimicrobial peptides like Tamm-Horsfall protein. It is also frequently prescribed for Prameha (a clinical entity covering diabetes and metabolic syndrome), where it helps normalize glucose tolerance and lipid profiles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chandraprabha Vati.